145 related articles for article (PubMed ID: 27406795)
1. Discovery of 2-((3-cyanopyridin-2-yl)thio)acetamides as human lactate dehydrogenase A inhibitors to reduce the growth of MG-63 osteosarcoma cells: Virtual screening and biological validation.
Cui W; Lv W; Qu Y; Ma R; Wang YW; Xu YJ; Wu D; Chen X
Bioorg Med Chem Lett; 2016 Aug; 26(16):3984-7. PubMed ID: 27406795
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
Cao W; Fang L; Teng S; Chen H; Wang Z
Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
[TBL] [Abstract][Full Text] [Related]
3. Identification of human lactate dehydrogenase A inhibitors with anti-osteosarcoma activity through cell-based phenotypic screening.
Wang F; Zhao Q; Liu J; Wang Z; Kong D
Bioorg Med Chem Lett; 2020 Feb; 30(4):126909. PubMed ID: 31879209
[TBL] [Abstract][Full Text] [Related]
4. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
Chen CY; Feng Y; Chen JY; Deng H
Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Cdc25A Lead Inhibitors with a Novel Chemotype by Virtual Screening: Application of Pharmacophore Modeling Based on a Training Set with a Limited Number of Unique Components.
Ge YS; Han QQ; Duan W; Zhang JQ; Chen K; Wan JJ; Liu Y; Liu D
ChemMedChem; 2017 Mar; 12(6):438-447. PubMed ID: 28198152
[TBL] [Abstract][Full Text] [Related]
6. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor screening of lactate dehydrogenase C4 from black-lipped pika in the Western Sichuan Plateau.
Zhang Q; He Q; Xue F; Ma J
Biosci Biotechnol Biochem; 2014; 78(4):651-4. PubMed ID: 25036963
[TBL] [Abstract][Full Text] [Related]
8. Screening of novel inhibitors targeting lactate dehydrogenase A via four molecular docking strategies and dynamics simulations.
Sun R; Li X; Li Y; Zhang X; Li X; Li X; Shi Z; Bao J
J Mol Model; 2015 May; 21(5):133. PubMed ID: 25934158
[TBL] [Abstract][Full Text] [Related]
9. Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations.
Zhou Y; Tao P; Wang M; Xu P; Lu W; Lei P; You Q
Eur J Med Chem; 2019 Sep; 177():105-115. PubMed ID: 31129449
[TBL] [Abstract][Full Text] [Related]
10. Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase.
Dragovich PS; Fauber BP; Corson LB; Ding CZ; Eigenbrot C; Ge H; Giannetti AM; Hunsaker T; Labadie S; Liu Y; Malek S; Pan B; Peterson D; Pitts K; Purkey HE; Sideris S; Ultsch M; VanderPorten E; Wei B; Xu Q; Yen I; Yue Q; Zhang H; Zhang X
Bioorg Med Chem Lett; 2013 Jun; 23(11):3186-94. PubMed ID: 23628333
[TBL] [Abstract][Full Text] [Related]
11. Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening.
Buonfiglio R; Ferraro M; Falchi F; Cavalli A; Masetti M; Recanatini M
J Chem Inf Model; 2013 Nov; 53(11):2792-7. PubMed ID: 24138094
[TBL] [Abstract][Full Text] [Related]
12. Discovery, synthesis and biological evaluation of 2-(4-(N-phenethylsulfamoyl)phenoxy)acetamides (SAPAs) as novel sphingomyelin synthase 1 inhibitors.
Li YL; Qi XY; Jiang H; Deng XD; Dong YP; Ding TB; Zhou L; Men P; Chu Y; Wang RX; Jiang XC; Ye DY
Bioorg Med Chem; 2015 Sep; 23(18):6173-84. PubMed ID: 26314925
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity screening to identify novel anti-osteosarcoma therapeutics targeting pyruvate dehydrogenase kinase 2.
Cao W; Wang Z; Han X; Liu J; Wang W
Bioorg Med Chem Lett; 2019 Oct; 29(20):126665. PubMed ID: 31495556
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of N-(3-Trifluoroacetyl-indol-7-yl) Acetamides for Potential In Vitro Antiplasmodial Properties.
Mphahlele MJ; Mmonwa MM; Choong YS
Molecules; 2017 Jul; 22(7):. PubMed ID: 28671598
[TBL] [Abstract][Full Text] [Related]
15. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation.
Xiang S; Huang D; He Q; Li J; Tam KY; Zhang SL; He Y
Eur J Med Chem; 2020 Oct; 203():112579. PubMed ID: 32688200
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.
Gao S; Tu DN; Li H; Jiang JX; Cao X; You JB; Zhou XQ
Biomed Pharmacother; 2016 Jul; 81():388-393. PubMed ID: 27261617
[TBL] [Abstract][Full Text] [Related]
17. Discovery of human lactate dehydrogenase A (LDHA) inhibitors as anticancer agents to inhibit the proliferation of MG-63 osteosarcoma cells.
Fang A; Zhang Q; Fan H; Zhou Y; Yao Y; Zhang Y; Huang X
Medchemcomm; 2017 Aug; 8(8):1720-1726. PubMed ID: 30108883
[TBL] [Abstract][Full Text] [Related]
18. Human lactate dehydrogenase a inhibitors: a molecular dynamics investigation.
Shi Y; Pinto BM
PLoS One; 2014; 9(1):e86365. PubMed ID: 24466056
[TBL] [Abstract][Full Text] [Related]
19. 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.
Yan G; Hao L; Niu Y; Huang W; Wang W; Xu F; Liang L; Wang C; Jin H; Xu P
Eur J Med Chem; 2017 Sep; 137():462-475. PubMed ID: 28624701
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.
Ward RA; Brassington C; Breeze AL; Caputo A; Critchlow S; Davies G; Goodwin L; Hassall G; Greenwood R; Holdgate GA; Mrosek M; Norman RA; Pearson S; Tart J; Tucker JA; Vogtherr M; Whittaker D; Wingfield J; Winter J; Hudson K
J Med Chem; 2012 Apr; 55(7):3285-306. PubMed ID: 22417091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
